Genetics Generation Advancement (ROCO:4160) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4160 Genetics Generation Advancement Corp ROCO:4160
70 GF Score
Price NT$41.15
GF Value NT$51.35
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Genetics Generation Advancement FFO?

FFO (Funds from operations) only applies to REITs.

ROCO:4160
70GF Score
Genetics Generation Advancement Corp ROCO:4160
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genetics Generation Advancement (ROCO:4160) Overvalued in 2026?

Based on GuruFocus' analysis, Genetics Generation Advancement stock appears to be undervalued. The current stock price of NT$41.15 is trading 19.9% below its estimated GF Value™ of NT$51.35. GuruFocus considers Genetics Generation Advancement to be Modestly Undervalued.

Key valuation signals for ROCO:4160:

  • FFO:
  • GF Value™: NT$51.35 vs. price of NT$41.15 (19.9% below fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the ROCO:4160 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genetics Generation Advancement Business Description

Address No. 28, Lane 36, Xinhu 1st Road, 6th Floor, Neihu District, Taipei, TWN, 11494
Genetics Generation Advancement Corp is a Taiwan based company specialized in genetic testing and scientific information. It is engaged in providing services for the detection of genetic defects and prevention in newborns. Their main services include amniotic fluid chromosome chip screening, pre-implantation genetic diagnosis, and Molecular DNA testing diagnostics. The company is focused on the majority of areas of maternal precision medicine, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection, and precise health management. The business units of the company are the Genetic Testing Unit and Informatics business unit.
70GF Score

Get the complete analysis for ROCO:4160

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$41.15
Price
NT$51.35
GF Value